University of Alabama at Birmingham (UAB) Pediatric CBD Program
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Seizures
Related studies linked through entity extraction aliases.
Assessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizures.
- Status
- UNKNOWN
- Phase
- NA
Epidemiology Study on Neonatal Seizure
- Status
- RECRUITING
- Phase
- N/A
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
- Status
- COMPLETED
- Phase
- PHASE3
Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest
- Status
- COMPLETED
- Phase
- NA
Novel Epidermal Recording and Detection of Seizures
- Status
- TERMINATED
- Phase
- N/A
microEEG for Neonatal Apnea, Bradycardia and Desaturation
- Status
- UNKNOWN
- Phase
- N/A
A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection
- Status
- COMPLETED
- Phase
- NA
Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management
- Status
- TERMINATED
- Phase
- PHASE4
Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation
- Status
- COMPLETED
- Phase
- N/A
EEG in Resuscitated In-hospital Patients
- Status
- TERMINATED
- Phase
- N/A
Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
- Status
- WITHDRAWN
- Phase
- N/A
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- Status
- RECRUITING
- Phase
- NA
Treatment Resistant Epilepsy and N-Acetyl Cysteine
- Status
- WITHDRAWN
- Phase
- NA
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
- Status
- COMPLETED
- Phase
- PHASE2
Seizure Prophylaxis in Aneurysm Repair
- Status
- TERMINATED
- Phase
- PHASE4